Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Mar 15;338(Pt 3):777–782.

Amyloid precursor protein metabolism in fibroblasts from individuals with one, two or three copies of the amyloid precursor protein (APP) gene.

M Racchi 1, J A Johnston 1, F M Flood 1, R F Cowburn 1, S Govoni 1
PMCID: PMC1220116  PMID: 10051452

Abstract

Protein kinase C (PKC)-activated modulation of amyloid precursor protein (APP) metabolism has been investigated in natural models of altered APP expression due to the presence of one, two or three copies of the APP gene. We show that levels of APP present in human skin fibroblasts strongly influence the effect of PKC activation of soluble APP (sAPP) release. Thus fibroblasts derived from a patient with a deletion in chromosome 21 including the APP locus (Delta21) had lower levels of both APP mRNA and cell-associated APP, and showed an exaggerated phorbol-ester-induced sAPP release, when compared with fibroblasts from control individuals. In contrast, fibroblasts from chromosome 21 trisomic Down's syndrome patients failed to show a concentration-dependent response to phorbol ester treatment. These results suggest that the levels of APP expression can affect the degree of response to PKC-mediated modulation of the metabolism of this protein.

Full Text

The Full Text of this article is available as a PDF (153.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. P., Esch F. S., Keim P. S., Sambamurti K., Lieberburg I., Robakis N. K. Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett. 1991 Jul 8;128(1):126–128. doi: 10.1016/0304-3940(91)90775-o. [DOI] [PubMed] [Google Scholar]
  2. Annerén G., Edman B. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene. APMIS Suppl. 1993;40:71–79. [PubMed] [Google Scholar]
  3. Bergamaschi S., Binetti G., Govoni S., Wetsel W. C., Battaini F., Trabucchi M., Bianchetti A., Racchi M. Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci Lett. 1995 Dec 1;201(1):1–5. doi: 10.1016/0304-3940(95)12168-4. [DOI] [PubMed] [Google Scholar]
  4. Checler F. Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem. 1995 Oct;65(4):1431–1444. doi: 10.1046/j.1471-4159.1995.65041431.x. [DOI] [PubMed] [Google Scholar]
  5. Chettouh Z., Croquette M. F., Delobel B., Gilgenkrants S., Leonard C., Maunoury C., Prieur M., Rethoré M. O., Sinet P. M., Chery M. Molecular mapping of 21 features associated with partial monosomy 21: involvement of the APP-SOD1 region. Am J Hum Genet. 1995 Jul;57(1):62–71. [PMC free article] [PubMed] [Google Scholar]
  6. Dünki R. M., Schmid G. B., Scheidegger P., Stassen H. H., Bomben G., Propping P. Reliable computer-assisted classification of the EEG: EEG variants in index cases and their first degree relatives. Am J Med Genet. 1996 Feb 16;67(1):1–8. doi: 10.1002/(SICI)1096-8628(19960216)67:1<1::AID-AJMG1>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  7. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., Ward P. J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990 Jun 1;248(4959):1122–1124. doi: 10.1126/science.2111583. [DOI] [PubMed] [Google Scholar]
  8. Godridge H., Reynolds G. P., Czudek C., Calcutt N. A., Benton M. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):775–778. doi: 10.1136/jnnp.50.6.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldgaber D., Lerman M. I., McBride O. W., Saffiotti U., Gajdusek D. C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 1987 Feb 20;235(4791):877–880. doi: 10.1126/science.3810169. [DOI] [PubMed] [Google Scholar]
  10. Govoni S., Bergamaschi S., Racchi M., Battaini F., Binetti G., Bianchetti A., Trabucchi M. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology. 1993 Dec;43(12):2581–2586. doi: 10.1212/wnl.43.12.2581. [DOI] [PubMed] [Google Scholar]
  11. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 1992 Sep 24;359(6393):322–325. doi: 10.1038/359322a0. [DOI] [PubMed] [Google Scholar]
  12. Henriksson T., Barbour R. M., Braa S., Ward P., Fritz L. C., Johnson-Wood K., Chung H. D., Burke W., Reinikainen K. J., Riekkinen P. Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay. J Neurochem. 1991 Mar;56(3):1037–1042. doi: 10.1111/j.1471-4159.1991.tb02026.x. [DOI] [PubMed] [Google Scholar]
  13. Hof P. R., Bouras C., Perl D. P., Sparks D. L., Mehta N., Morrison J. H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol. 1995 Apr;52(4):379–391. doi: 10.1001/archneur.1995.00540280065020. [DOI] [PubMed] [Google Scholar]
  14. Johnston J. A., Norgren S., Annerén G., Cowburn R. F., Lannfelt L. A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA. Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):77–84. doi: 10.1016/s0169-328x(96)00160-x. [DOI] [PubMed] [Google Scholar]
  15. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  16. Lai F., Williams R. S. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989 Aug;46(8):849–853. doi: 10.1001/archneur.1989.00520440031017. [DOI] [PubMed] [Google Scholar]
  17. Mann D. M., Yates P. O., Marcyniuk B., Ravindra C. R. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol. 1986 Sep-Oct;12(5):447–457. doi: 10.1111/j.1365-2990.1986.tb00053.x. [DOI] [PubMed] [Google Scholar]
  18. Nitsch R. M., Growdon J. H. Role of neurotransmission in the regulation of amyloid beta-protein precursor processing. Biochem Pharmacol. 1994 Apr 20;47(8):1275–1284. doi: 10.1016/0006-2952(94)90325-5. [DOI] [PubMed] [Google Scholar]
  19. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988 Feb 11;331(6156):525–527. doi: 10.1038/331525a0. [DOI] [PubMed] [Google Scholar]
  20. Racchi M., Baetta R., Salvietti N., Ianna P., Franceschini G., Paoletti R., Fumagalli R., Govoni S., Trabucchi M., Soma M. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J. 1997 Mar 15;322(Pt 3):893–898. doi: 10.1042/bj3220893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Racchi M., Bergamaschi S., Govoni S., Wetsel W. C., Bianchetti A., Binetti G., Battaini F., Trabucchi M. Characterization and distribution of protein kinase C isoforms in human skin fibroblasts. Arch Biochem Biophys. 1994 Oct;314(1):107–111. doi: 10.1006/abbi.1994.1417. [DOI] [PubMed] [Google Scholar]
  22. Racchi M., Ianna P., Binetti G., Trabucchi M., Govoni S. Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease. Biochem J. 1998 Mar 15;330(Pt 3):1271–1275. doi: 10.1042/bj3301271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Roland B., Cox D. M., Hoar D. I., Fowlow S. B., Robertson A. S. A familial interstitial deletion of the long arm of chromosome 21. Clin Genet. 1990 Jun;37(6):423–428. doi: 10.1111/j.1399-0004.1990.tb03525.x. [DOI] [PubMed] [Google Scholar]
  24. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C. L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med. 1989 Jun 1;320(22):1446–1452. doi: 10.1056/NEJM198906013202203. [DOI] [PubMed] [Google Scholar]
  25. Sambamurti K., Shioi J., Anderson J. P., Pappolla M. A., Robakis N. K. Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J Neurosci Res. 1992 Oct;33(2):319–329. doi: 10.1002/jnr.490330216. [DOI] [PubMed] [Google Scholar]
  26. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996 Aug;2(8):864–870. doi: 10.1038/nm0896-864. [DOI] [PubMed] [Google Scholar]
  27. Selkoe D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem. 1996 Aug 2;271(31):18295–18298. doi: 10.1074/jbc.271.31.18295. [DOI] [PubMed] [Google Scholar]
  28. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 1992 Sep 24;359(6393):325–327. doi: 10.1038/359325a0. [DOI] [PubMed] [Google Scholar]
  29. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. M., Tintner R., Frangione B. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992 Oct 2;258(5079):126–129. doi: 10.1126/science.1439760. [DOI] [PubMed] [Google Scholar]
  30. Sisodia S. S. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6075–6079. doi: 10.1073/pnas.89.13.6075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., Price D. L. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 1990 Apr 27;248(4954):492–495. doi: 10.1126/science.1691865. [DOI] [PubMed] [Google Scholar]
  32. Slack B. E., Nitsch R. M., Livneh E., Kunz G. M., Jr, Breu J., Eldar H., Wurtman R. J. Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase C alpha. J Biol Chem. 1993 Oct 5;268(28):21097–21101. [PubMed] [Google Scholar]
  33. Tanzi R. E., McClatchey A. I., Lamperti E. D., Villa-Komaroff L., Gusella J. F., Neve R. L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988 Feb 11;331(6156):528–530. doi: 10.1038/331528a0. [DOI] [PubMed] [Google Scholar]
  34. Trejo J., Massamiri T., Deng T., Dewji N. N., Bayney R. M., Brown J. H. A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene. J Biol Chem. 1994 Aug 26;269(34):21682–21690. [PubMed] [Google Scholar]
  35. Wisniewski K. E., Dalton A. J., McLachlan C., Wen G. Y., Wisniewski H. M. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology. 1985 Jul;35(7):957–961. doi: 10.1212/wnl.35.7.957. [DOI] [PubMed] [Google Scholar]
  36. Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985 Mar;17(3):278–282. doi: 10.1002/ana.410170310. [DOI] [PubMed] [Google Scholar]
  37. Wulfsberg E. A., Carrel R. E., Klisak I. J., O'Brien T. J., Sykes J. A., Sparkes R. S. Normal superoxide dismutase-1 (SOD-1) activity with deletion of chromosome band 21q21 supports localization of SOD-1 locus to 21q22. Hum Genet. 1983;64(3):271–272. doi: 10.1007/BF00279408. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES